Equity

Share-Based Payment - Unrecognized Cost of Nonvested Awards

Abbott Share-Based Payment - Unrecognized Cost of Nonvested Awards decreased by 19.1% to $467.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from $462.00M to $467.00M. Over 3 years (FY 2022 to FY 2025), Share-Based Payment - Unrecognized Cost of Nonvested Awards shows relatively stable performance with a -1.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2025

How to read this metric

An increase suggests higher future non-cash compensation expenses, which may impact future operating margins.

Detailed definition

This represents the total compensation expense for stock-based awards that has been granted but not yet recognized in th...

Peer comparison

Common in large-cap companies that utilize equity-based compensation to align employee and shareholder interests.

Metric ID: share_based_payment_unrecognized_cost

Historical Data

15 periods
 Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$713.00M$600.00M$494.00M$760.00M$660.00M$560.00M$450.00M$787.00M$675.00M$567.00M$462.00M$790.00M$683.00M$577.00M$467.00M
QoQ Change-15.8%-17.7%+53.8%-13.2%-15.2%-19.6%+74.9%-14.2%-16.0%-18.5%+71.0%-13.5%-15.5%-19.1%
YoY Change-7.4%-6.7%-8.9%+3.6%+2.3%+1.3%+2.7%+0.4%+1.2%+1.8%+1.1%
Range$450.00M$790.00M
CAGR-11.4%
Avg YoY Growth-0.8%
Median YoY Growth+1.2%
Current Streak3 quarters decline

Frequently Asked Questions

What is Abbott's share-based payment - unrecognized cost of nonvested awards?
Abbott (ABT) reported share-based payment - unrecognized cost of nonvested awards of $467.00M in Q4 2025.
How has Abbott's share-based payment - unrecognized cost of nonvested awards changed year-over-year?
Abbott's share-based payment - unrecognized cost of nonvested awards increased by 1.1% year-over-year, from $462.00M to $467.00M.
What is the long-term trend for Abbott's share-based payment - unrecognized cost of nonvested awards?
Over 3 years (2022 to 2025), Abbott's share-based payment - unrecognized cost of nonvested awards has grown at a -1.9% compound annual growth rate (CAGR), from $494.00M to $467.00M.
What does share-based payment - unrecognized cost of nonvested awards mean?
The amount of future compensation expense for stock awards that have been granted but not yet earned by employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.